Literature DB >> 10627860

The care of patients with diabetic nephropathy: audit, feedback, and improvement.

E J Dunn1, C J Burton, T G Feest.   

Abstract

Diabetic nephropathy is the commonest cause of end-stage renal failure in the developed world. The quality of care of 152 patients with diabetic nephropathy was assessed at the time of referral to a single nephrologist. The type II diabetics (62%) were older than the type I diabetics (38%) (mean 65 years vs. 48 years). The mean duration of diabetes was 17 years. Significant cardiovascular disease was present in 52%. There was diabetic retinopathy in 84% of the type I diabetics and 53% of the type II diabetics. Overall, 63% had hypertension at referral (St Vincent Declaration criteria), untreated in 25%. ACE inhibitors were not prescribed in 48% when no contraindications to their use were present. Glycosylated haemoglobin was > 9.1% in 29%. Twenty were prescribed medications inappropriate to their renal function. Of patients with ischaemic heart disease and serum cholesterol > 5.5 mmol/l, 82% were untreated; 82% of patients with secondary hyperparathyroidism were also untreated. At initial referral, many patients' care was sub-optimal. Referral was too late for adequate preparation for renal replacement therapy in 33%. Following a process of education and feedback of the results to referring practitioners, the timing of referral improved. We emphasize the need for closer co-operation between those managing diabetic patients with nephropathy to optimize their care.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10627860     DOI: 10.1093/qjmed/92.8.443

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  5 in total

1.  Defining quality diabetes care in the new health system.

Authors:  Joel B Braunstein
Journal:  Curr Diab Rep       Date:  2003-08       Impact factor: 4.810

Review 2.  Underprescription of beneficial medicines in older people: causes, consequences and prevention.

Authors:  Antonio Cherubini; Andrea Corsonello; Fabrizia Lattanzio
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

3.  Indications for and utilization of ACE inhibitors in older individuals with diabetes. Findings from the National Health and Nutrition Examination Survey 1999 to 2002.

Authors:  Allison B Rosen
Journal:  J Gen Intern Med       Date:  2006-04       Impact factor: 5.128

4.  Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes.

Authors:  Allison B Rosen; Andrew J Karter; Jennifer Y Liu; Joe V Selby; Eric C Schneider
Journal:  J Gen Intern Med       Date:  2004-06       Impact factor: 5.128

5.  ACE inhibitor and angiotensin II type 1 receptor antagonist therapies in elderly patients with diabetes mellitus: are they underutilized?

Authors:  Lamioko Shika Pappoe; Wolfgang C Winkelmayer
Journal:  Drugs Aging       Date:  2010-02-01       Impact factor: 3.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.